Ms. Weintraub et al., CLEARANCE OF CHYLOMICRON REMNANTS IN NORMOLIPIDEMIC PATIENTS WITH CORONARY-ARTERY DISEASE - CASE-CONTROL STUDY OVER 3 YEARS, BMJ. British medical journal, 312(7036), 1996, pp. 935-939
Objective-To test the hypothesis that subjects who clear chylomicron r
emnants slowly from plasma may be at higher risk of coronary artery di
sease than indicated by their fasting plasma lipid concentrations. Des
ign-Case control study over three years. Setting-An 800 bed general mu
nicipal hospital. Subjects-85 normolipidaemic patients with coronary a
rtery disease selected prospectively and matched with 85 normolipidaem
ic subjects with normal coronary arteries on angiography. Intervention
s-All subjects were given a vitamin A fat loading test which specifica
lly labels intestinal lipoproteins with retinyl palmitate. Main outcom
e measure-Postprandial lipoprotein metabolism. Results-The area below
the chylomicron remnant retinyl palmitate curve was significantly incr
eased in the coronary artery disease group as compared with the contro
ls (mean 23.4 (SD 15.0) v 15.3 (8.9) mu mol/l.h; 95% confidence interv
al of difference 4.37 to 11.82). Conclusions-Normolipidaemic patients
with coronary artery disease had significantly higher concentrations o
f chylomicron remnants in plasma than normolipidaemic subjects with no
rmal coronary vessels. This may explain the mechanism underlying the s
usceptibility to atherosclerosis of coronary artery disease patients w
ith normal fasting lipid values. As diet and drugs can ameliorate the
accumulation of postprandial lipoproteins in plasma, the concentration
of chylomicron remnants should be measured in patients at high risk o
f coronary artery disease.